Evidence map›Paper›PMID 24398689›Full record

ArticleThe Journal of biological chemistry2014

Lipopolysaccharide-induced lung injury involves the nitration-mediated activation of RhoA.

Ruslan Rafikov, Christiana Dimitropoulou, Saurabh Aggarwal, Archana Kangath, Christine Gross, Daniel Pardo, Shruti Sharma, Agnieszka Jezierska-Drutel, Vijay Patel, Connie Snead and 5 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Nitration in cancer signaling.Redox biology · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Calpain Promotes LPS-induced Lung Endothelial Barrier Dysfunction via Cleavage of Talin.American journal of respiratory cell and molecular biology · 2023
    Article
  13. Article
  14. Article
  15. Cortactin loss protects against hemin-induced acute lung injury in sickle cell disease.American journal of physiology. Lung cellular and molecular physiology · 2022
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Ruslan RafikovFrom the Program in Pulmonary Vascular Disease, Vascular Biology Center and.
Christiana Dimitropoulou
Saurabh Aggarwal
Archana Kangath
Christine Gross
Daniel Pardo
Shruti Sharma
Agnieszka Jezierska-Drutel
Vijay Patel
Connie Snead
Rudolf Lucas
Alexander Verin
David Fulton
John D Catravas
Stephen M Black
Center for Vascular Biology Research · USAugusta University · US

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
PERINATAL REGULATION OF THE ENDOTHELIAL NOS GENER01HL060190 · NHLBI · UNIVERSITY OF MONTANA · PI Stephen M Black · 1998 to 2026
$7.1M
NHLBI NIH HHS P01HL0101902NHLBI NIH HHS P01 HL101902NHLBI NIH HHS R01 HL060190
6 · The paper itself

Abstract

Acute lung injury (ALI) is characterized by increased endothelial hyperpermeability. Protein nitration is involved in the endothelial barrier dysfunction in LPS-exposed mice. However, the nitrated proteins involved in this process have not been identified. The activation of the small GTPase RhoA is a critical event in the barrier disruption associated with LPS. Thus, in this study we evaluated the possible role of RhoA nitration in this process. Mass spectroscopy identified a single nitration site, located at Tyr(34) in RhoA. Tyr(34) is located within the switch I region adjacent to the nucleotide-binding site. Utilizing this structure, we developed a peptide designated NipR1 (nitration inhibitory peptide for RhoA 1) to shield Tyr(34) against nitration. TAT-fused NipR1 attenuated RhoA nitration and barrier disruption in LPS-challenged human lung microvascular endothelial cells. Further, treatment of mice with NipR1 attenuated vessel leakage and inflammatory cell infiltration and preserved lung function in a mouse model of ALI. Molecular dynamics simulations suggested that the mechanism by which Tyr(34) nitration stimulates RhoA activity was through a decrease in GDP binding to the protein caused by a conformational change within a region of Switch I, mimicking the conformational shift observed when RhoA is bound to a guanine nucleotide exchange factor. Stopped flow kinetic analysis was used to confirm this prediction. Thus, we have identified a new mechanism of nitration-mediated RhoA activation involved in LPS-mediated endothelial barrier dysfunction and show the potential utility of "shielding" peptides to prevent RhoA nitration in the management of ALI.

Indexed as

Acute Lung InjuryAmino Acid SequenceAnimalsBronchoalveolar Lavage FluidCytokinesDisease Models, AnimalEndothelial CellsEnzyme ActivationHumansLipopolysaccharidesLung InjuryMaleMiceMice, Inbred C57BLMicrovesselsMolecular Sequence DataCytokinesLipopolysaccharidesNitric Oxide Synthase Type IIIPeptidesProtective AgentsrhoA GTP-Binding ProteinTyrosineEnzymologyLung InjuryPost-translational ModificationProtein StructureRecombinant Protein ExpressionRedox RegulationSuperoxide Ion

Identifiers

PMID24398689
PMCPMC3931033
OpenAlexW2040200538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.